References:
  1. Leon MB, Smith CR, Mack M et al; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.
  2. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451-96.
  3. Nishimura RA, Otto CM, Bonow RO et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63: 2438–88.
  4. Puri R, Iung B, Cohen DJ, Rodés-Cabau J. TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. Eur Heart J . 2016;37:2217-25.
  5. Dubois C, Coosemans M, Rega F et al. Prospective evaluation of clinical outcomes in all-comer high-risk patients with aortic valve stenosis undergoing medical treatment, transcatheter or surgical aortic valve implantation following heart team assessment.Interact Cardiovasc Thorac Surg . 2013;17:492-500.
  6. Kaier K, Gutmann A, Vach W et al. “Heart Team” decision making in elderly patients with symptomatic aortic valve stenosis who underwent AVR or TAVI – a look behind the curtain. Results of the prospective TAVI Calculation of Costs Trial (TCCT). EuroIntervention . 2015;11:793-8.
  7. Meyer SR, Shanks M, Tyrrell BD et al. Outcomes of consecutive patients referred for consideration for transcatheter aortic valve implantation from encompassing health-care region. Am J Cardiol. 2013;112:1450-4.
  8. Kappetein AP, Head SJ, Généreux P et al; Valve Academic Research Consortium (VARC)-2 Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J . 2012; 33:2403-18
  9. Schumacher M, Holländer N, Schwarzer G, Binder H, Sauerbrei W. Prognostic Factor Studies. In: Crowley J, Hoering A, editors.Handbook of Statistics in Clinical Oncology . 3 ed. Boca Raton: CRC Press; 2012. p.415-69.
  10. Serruys PW, Morice MC, Kappetein AP et al; SYNTAX Investigators. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N Engl J Med . 2009;360:961–72.
  11. Smith CR, Leon MB, Mack MJ, PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients.N Engl J Med 2011;364:2187–98.
  12. Coylewright M, Mack MJ, Holmes DR, O‘Gara PT. A call for an evidence-based approach to the Heart Team for patients with severe aortic stenosis. J Am Coll Cardiol . 2015;65:1472-80.
  13. Mack MJ, Leon MB, Thourani VH et al; PARTNER 3 Investigators. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med . 2019;380:1695-705.
  14. Popma JJ, Deeb GM, Yakubov SJ et al; Evolut Low Risk Trial Investigators. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med2019;380:1706-15.
  15. Iung B, Cachier A, Baron G et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005; 26: 2714-20.
  16. Nombela-Franco L, Ribeiro HB, Urena M et al. Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol2014;63:2643-58.
  17. Bedogni F, Latib A, De Marco F et al. Interplay Between Mitral Regurgitation and Transcatheter Aortic Valve Replacement With the CoreValve Revalving System: A Multicenter Registry. Circulation  2013;128:2145–53.
  18. Nombela-Franco L, Eltchaninoff H, Zahn R et al. Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis. Heart 2015;101:1395-405.
  19. Barreiro CJ, Patel ND, Fitton TP et al. Aortic valve replacement and concomitant mitral valve regurgitation in the elderly: impact on survival and functional outcome. Circulation 2005;112:I443–7.
  20. Ruel M, Kapila V, Price J, Kulik A, Burwash IG, Mesana TG. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement. Circulation 2006;114:I541–6.
  21. Litmathe J, Boeken U, Kurt M, Feindt P, Gams E. Predictive risk factors in double-valve replacement (AVR and MVR) compared to isolated aortic valve replacement. Thorac Cardiovasc Surg2006;54:459-63.
  22. Afilalo J, Mottillo S, Eisenberg MJ et al. Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcomes  2012;5:222–8.
  23. Sundermann S, Dademasch A, Rastan A et al. One-year follow-up of patients undergoing elective cardiac surgery assessed with the comprehensive assessment of frailty test and its simplified form. Interact Cardiovasc Thorac Surg  2011; 13: 119–23
  24. Green P, Woglom AE, Genereux P. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv  2012;5:974–81
  25. Lindman BR, Alexander KP, O’gara PT, Afilalo J. Futility, benefit, and transcatheter aortic valve replacement. JACC Cardiovasc Interv 2014;7:707–16.
  26. Rattazzi M, Bertacco E, Del Vecchio A, Puato M, Faggin E, Pauletto P. Aortic valve calcification in chronic kidney disease. Nephrology Dialysis Transplantation 2013;28:2968-76.
  27. Kumar N, Khera R, Garg N et al. Comparison of Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Chronic Kidney Disease. Am J Cardiol 2018;121:343-8.
  28. Leon MB, Smith CR, Mack MJ et al; PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609–20.
  29. Makkar RR, Fontana GP, Jilaihawi H et al; PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366:1696–704.